Vigilance, rather than alarm, is needed to manage adverse events associated with bisphosphonate use for osteoporosis

Author:  

Publisher: Adis International

ISSN: 1172-0360

Source: Drugs & Therapy Perspectives, Vol.28, Iss.2, 2012-02, pp. : 20-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract